IL134597A0 - Therapy for staphylococcus aureus - Google Patents

Therapy for staphylococcus aureus

Info

Publication number
IL134597A0
IL134597A0 IL13459798A IL13459798A IL134597A0 IL 134597 A0 IL134597 A0 IL 134597A0 IL 13459798 A IL13459798 A IL 13459798A IL 13459798 A IL13459798 A IL 13459798A IL 134597 A0 IL134597 A0 IL 134597A0
Authority
IL
Israel
Prior art keywords
staphylococcus aureus
therapy
strains
strain
directed
Prior art date
Application number
IL13459798A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL134597A0 publication Critical patent/IL134597A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL13459798A 1997-08-22 1998-08-18 Therapy for staphylococcus aureus IL134597A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5671297P 1997-08-22 1997-08-22
PCT/US1998/017138 WO1999010006A1 (en) 1997-08-22 1998-08-18 Therapy for staphylococcus aureus

Publications (1)

Publication Number Publication Date
IL134597A0 true IL134597A0 (en) 2001-04-30

Family

ID=22006150

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13459798A IL134597A0 (en) 1997-08-22 1998-08-18 Therapy for staphylococcus aureus
IL134597A IL134597A (en) 1997-08-22 2000-02-17 Use of an antibiotic compound for the preparation of a drug for the treatment of diseases that can be attributed to Staphylococcus aureus

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL134597A IL134597A (en) 1997-08-22 2000-02-17 Use of an antibiotic compound for the preparation of a drug for the treatment of diseases that can be attributed to Staphylococcus aureus

Country Status (23)

Country Link
US (1) US5994297A (da)
EP (1) EP0897725B1 (da)
JP (1) JP2001513573A (da)
KR (1) KR100589548B1 (da)
CN (1) CN1276728A (da)
AT (1) ATE278413T1 (da)
AU (1) AU747418B2 (da)
BR (1) BR9811917A (da)
CA (1) CA2301589A1 (da)
CZ (1) CZ299098B6 (da)
DE (1) DE69826795T2 (da)
DK (1) DK0897725T3 (da)
EA (1) EA002602B1 (da)
ES (1) ES2229454T3 (da)
HU (1) HU226593B1 (da)
ID (1) ID24908A (da)
IL (2) IL134597A0 (da)
NO (1) NO327042B1 (da)
NZ (1) NZ502762A (da)
PT (1) PT897725E (da)
TR (1) TR200000475T2 (da)
UA (1) UA59410C2 (da)
WO (1) WO1999010006A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3006038T (pt) * 2008-08-30 2024-08-23 The Medicines Co Doses únicas de oritavancina para tratamento ou prevenção de uma infeção bacteriana
CN101928331B (zh) * 2009-06-26 2014-05-28 上海来益生物药物研究开发中心有限责任公司 一种化合物及其应用
KR102237887B1 (ko) 2013-03-15 2021-04-07 멜린타 서브시디어리 코프. 항생제를 사용하여 과체중 및 비만 환자에서 감염을 치료하는 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW457248B (en) * 1994-01-28 2001-10-01 Lilly Co Eli Glycopeptide antibiotic derivatives

Also Published As

Publication number Publication date
KR100589548B1 (ko) 2006-06-15
PT897725E (pt) 2004-12-31
UA59410C2 (uk) 2003-09-15
BR9811917A (pt) 2000-08-15
IL134597A (en) 2007-09-20
DK0897725T3 (da) 2004-12-13
EA002602B1 (ru) 2002-06-27
ES2229454T3 (es) 2005-04-16
EA200000250A1 (ru) 2000-08-28
HUP0002920A2 (hu) 2001-01-29
NZ502762A (en) 2001-10-26
US5994297A (en) 1999-11-30
AU8913798A (en) 1999-03-16
NO20000851D0 (no) 2000-02-21
EP0897725B1 (en) 2004-10-06
JP2001513573A (ja) 2001-09-04
EP0897725A2 (en) 1999-02-24
CZ299098B6 (cs) 2008-04-23
KR20010023108A (ko) 2001-03-26
HU226593B1 (en) 2009-04-28
EP0897725A3 (en) 2000-02-09
CZ2000619A3 (en) 2001-05-16
DE69826795T2 (de) 2005-10-06
NO327042B1 (no) 2009-04-06
DE69826795D1 (de) 2004-11-11
NO20000851L (no) 2000-02-21
HUP0002920A3 (en) 2001-12-28
CA2301589A1 (en) 1999-03-04
ATE278413T1 (de) 2004-10-15
TR200000475T2 (tr) 2000-08-21
ID24908A (id) 2000-08-31
CN1276728A (zh) 2000-12-13
AU747418B2 (en) 2002-05-16
WO1999010006A1 (en) 1999-03-04

Similar Documents

Publication Publication Date Title
PA8432701A1 (es) Derivados triciclicos sustituidos con fenilamino.
HN2000000051A (es) Derivados heterociclicos utiles como agentes anticancerosos
DE69421639D1 (de) Aza-Zyklohexapeptide
IL189629A0 (en) Compositions containing human ctla-4 antibodies
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
WO2003037259A3 (en) Methods for the prevention or treatment of bacterial and fungal infections
AU2005099A (en) Methods and compositions for the treatment and prevention of (staphylococcus aureus) infections
MX232591B (es) Procedimiento para tratar infecciones oculares con azitromicina
FI924424A0 (fi) Hjaertskyddande tokoferolanaloger.
TNSN04035A1 (fr) Azithromycine en dose unique
ES2136457T3 (es) Dimeros unidos covalentemente de antibioticos glucopeptidicos.
ES2140184T3 (es) Dimeros unidos covalentemente de antibioticos glicopeptidicos.
EA200100700A1 (ru) Гены и белки и их применение
IL134597A0 (en) Therapy for staphylococcus aureus
EP1066045A4 (en) Mammalian-derived peptides for the treatment of microbial infection
ES2087535T3 (es) Procedimiento para la preparacion enzimatica de macrolactona.
EA200100701A1 (ru) Белки наружной поверхности, их гены и их применение
SE9001111D0 (sv) Supportive use
ECSP951463A (es) Compuestos biciclicos

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed